A drug used to prevent seizures or reduce their severity.
| Member | Definition | Class |
|---|
| 10-hydroxycarbamazepine | A dibenzoazepine that is 5H-dibenzo[b,f]azepine, reduced across the C-10,11 positions and carrying a carbamoyl substituent at the azepine nitrogen and a hydroxy function at C-10. A voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects, it is related to oxcarbazepine and is an active metabolite of oxcarbazepine. | licarbazepine |
| 3,3-diethyl-2-pyrrolidinone | A pyrrolidin-2-one substituted by two ethyl groups at position 3. | 3,3-diethyl-2-pyrrolidinone |
| 6-methoxybenzoxazolinone | A 2-benzoxazolinone that is substituted by a methoxy group at position 6. | 6-methoxy-2-benzoxazolinone; Coixol |
| acacetin | A monomethoxyflavone that is the 4'-methyl ether derivative of apigenin. | 5,7-dihydroxy-4'-methoxyflavone |
| acetazolamide | | acetazolamide |
| adinazolam | A triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position. | adinazolam |
| alpha-asarone | The trans-isomer of asarone. | alpha-asarone |
| alprazolam | A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug. | alprazolam |
| aminoglutethimide | A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position. | aminoglutethimide |
| aminooxyacetic acid | A member of the class of hydroxylamines that is acetic acid substituted at postion 2 by an aminooxy group. It is a compound which inhibits aminobutyrate aminotransferase activity in vivo, resulting in increased levels of gamma-aminobutyric acid in tissues. | (aminooxy)acetic acid |
| androsterone | An androstanoid that is 5alpha-androstane having a hydroxy substituent at the 3alpha-position and an oxo group at the 17-position. It is a metabolite of dehydroepiandrosterone . | androsterone |
| arachidonoylserotonin | An N-acylserotonin obtained by formal condensation of the carboxy group of arachidonic acid with the primary amino group of serotonin. | N-arachidonoylserotonin |
| carbamazepine | A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant. | carbamazepine |
| carnosine | A dipeptide that is the N-(beta-alanyl) derivative of L-histidine. | carnosine zwitterion; carnosine |
| chlorazepate | A 1,4-benzodiazepinone in which the oxo group is at position 2, and which is substituted at positions 3, 5, and 7 by carboxy, phenyl and chloro groups, respectively. | clorazepic acid |
| clobazam | 7-Chloro-1H-1,5-benzodiazepine-2,4(3H,5H)-dione in which the hydrogen attached to the nitrogen at position 1 is substituted by a methyl group, whilst that attached to the other nitrogen is substituted by a phenyl group. It is used for the short-term management of acute anxiety and as an adjunct in the treatment of epilepsy in association with other antiepileptics. | clobazam |
| clonazepam | 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation. | clonazepam |
| clorazepate dipotassium | The compound of monopotassium clorazepate with potassium hydroxide. It is used for the management of anxiety disorders, for the short-term relief of anxiety, as adjunctive therapy in the management of epilepsy, and for the symptomatic relief of acute alcohol withdrawal. | dipotassium clorazepate |
| decan-4-olide | A gamma-lactone that is oxolan-2-one substituted by a hexyl group at position 5. | gamma-decalactone |
| diazepam | A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5. | diazepam |
| didesethylflurazepam | A primary amino compound resulting from the dealkylation of both ethyl groups of the anti-insomnia drug flurazepam. It is the major metabolite of flurazepam. | didesethylflurazepam |
| dizocilpine | An organic heterotetracyclic compound that is 1-methyl-8-azabicyclo[3.2.1]octane ortho-fused to two benzene rings at positions 2-3 and 6-7 (the 5S,10R-stereoisomer). It is a non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor and affects cognitive function, learning, and memory. | dizocilpine |
| dizocilpine maleate | A maleate salt obtained by reaction of dizocilpine with one equivalent of maleic acid. | dizocilpine maleate |
| eslicarbazepine acetate | The acetate ester, with S configuration, of licarbazepine. An anticonvulsant, it is approved for use in Europe and the United States as an adjunctive therapy for epilepsy. | eslicarbazepine acetate |
| estazolam | A triazolo[4,3-a][1,4]benzodiazepine having a phenyl group at position 6 and a chloro substituent at position 8. A short-acting benzodiazepine with general properties similar to diazepam, it is given by mouth as a hypnotic in the short-term management of insomnia. | estazolam |
| ethosuximide | A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures. | ethosuximide |
| ethotoin | An imidazolidine-2,4-dione that is hydantoin substituted by ethyl and phenyl at positions 3 and 5, respectively. An antiepileptic, it is less toxic than phenytoin but also less effective. | ethotoin |
| ezogabine | A substituted aniline that is benzene-1,2,4-triamine bearing ethoxycarbonyl and 4-fluorobenzyl substituents at positions N-1 and N-4 respectively. An anticonvulsant used to treat seizures associated with epilepsy in adults. | ezogabine |
| felbamate | The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy. | felbamate |
| flurazepam | A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a 2-(diethylamino)ethyl group, 2-fluorophenyl group and chloro group at positions 1, 5 and 7, respectively. It is a partial agonist of GABAA receptors and used for the treatment of insomnia. | flurazepam |
| gabapentin | A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome. | gabapentin |
| glutaurine | A dipeptide resulting from the formal condensation of the amino group of taurine with the gamma-carboxy group of L-glutamic acid. It was initially found in the parathyroid in 1980 and later in the brain of mammals. | glutaurine zwitterion; glutaurine |
| glutaurine | A dipeptide zwitterion that is glutaurine in which a proton has been transferred from the carboxy group to the alpha-amino group. | glutaurine zwitterion; glutaurine |
| hispidulin | A monomethoxyflavone that is scutellarein methylated at position 6. | hispidulin |
| L-cycloserine | A 4-amino-1,2-oxazolidin-3-one that has S configuration. An antibiotic isolated from Erwinia uredovora. | L-cycloserine |
| lamotrigine | A member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6. | lamotrigine |
| levetiracetam | A pyrrolidinone and carboxamide that is N-methylpyrrolidin-2-one in which one of the methyl hydrogens is replaced by an aminocarbonyl group, while another is replaced by an ethyl group (the S enantiomer). An anticonvulsant, it is used for the treatment of epilepsy in both human and veterinary medicine. | levetiracetam |
| lysine | An L-alpha-amino acid; the L-isomer of lysine. | L-Lysine zwitterion; L-lysine |
| magnesium sulfate | A magnesium salt having sulfate as the counterion. | magnesium sulfate |
| meclofenamate sodium anhydrous | A hydrate that is the monohydrate of the sodium salt of meclofenamic acid. It is used for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis. | sodium meclofenamate monohydrate |
| meclofenamic acid | An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis. | meclofenamic acid |
| melatonin | A member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans. | melatonin |
| mephenytoin | An imidazolidine-2,4-dione (hydantoin) in which the imidazolidine nucleus carries a methyl group at N-3 and has ethyl and phenyl substituents at C-5. An anticonvulsant, it is no longer available in the USA or the UK but is still studied largely because of its interesting hydroxylation polymorphism. | mephenytoin |
| mephobarbital | A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at N-1 by a methyl group and at C-5 by ethyl and phenyl groups. | mephobarbital |
| midazolam | An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively. | midazolam |
| midazolam hydrochloride | The hydrochloride salt of midazolam. | midazolam hydrochloride |
| mk 458 | The hydrochloride salt of naxagolide. | naxagolide hydrochloride |
| naxagolide | An organic heterotricyclic compound that is (4aR,10bR)-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazine substituted by propyl and hydroxy groups at positions 4 and 9, respectively. It is a potent dopamine D2-receptor agonist and its hydrochloride salt was under clinical development by Merck & Co as a potential antiparkinsonian agent (now discontinued). | naxagolide |
| nimetazepam | A nitrazepam which is substituted at positions 1 by a methyl group. It is used as an anticonvulsant and as a hypnotic for the short-term management of insomnia. | nimetazepam |
| nitrazepam | A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome). | nitrazepam |
| nordazepam | A 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety. | nordazepam |
| oxcarbazepine | A dibenzoazepine derivative, having a carbamoyl group at the ring nitrogen, substituted with an oxo group at C-4 of the azepeine ring which is also hydrogenated at C-4 and C-5. It is a anticholinergic anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy. | oxcarbazepine |
| palmidrol | An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid. | palmitoyl ethanolamide |
| palmitone | A dialkyl ketone that is hentriacontane in which the hydrogens at position 16 are replaced by an oxo group. | hentriacontan-16-one |
| paramethadione | | paramethadione |
| paxilline | An indole diterpene alkaloid with formula C27H33NO4 isolated from Penicillium paxilli. It is a potent inhibitor of large conductance Ca2(+)- and voltage-activated K(+) (BK)-type channels. | paxilline |
| perampanel | A member of the class of bipyridines that is 2,3'-bipyridin-6'-one substituted at positions 1' and 5' by phenyl and 2-cyanophenyl groups respectively. Used as an adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy. | perampanel |
| phenobarbital | A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups. | phenobarbital |
| phenytoin | A imidazolidine-2,4-dione that consists of hydantoin bearing two phenyl substituents at position 5. | phenytoin |
| pregabalin | A gamma-amino acid that is gamma-aminobutyric acid (GABA) carrying an isobutyl substitutent at the beta-position (the S-enantiomer). Binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. | pregabalin |
| prilocaine | An amino acid amide in which N-propyl-DL-alanine and 2-methylaniline have combined to form the amide bond; used as a local anaesthetic. | prilocaine |
| primidone | A pyrimidone that is dihydropyrimidine-4,6(1H,5H)-dione substituted by an ethyl and a phenyl group at position 5. It is used as an anticonvulsant for treatment of various types of seizures. | primidone |
| propofol | A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group. | propofol |
| pyrrolidine dithiocarbamate | A member of the class of dithiocarbamic acids that is the N-dithiocarboxy derivative of pyrrolidine. | pyrrolidine dithiocarbamate |
| ro 25-6981 | A member of the class of piperidines that is 4-benzylpiperidine substituted by a 3-hydroxy-3-(4-hydroxyphenyl)-2-methylpropyl group at position 1 (the 1R,2S-stereoisomer). It is a potent antagonist of the GluN2B subunit of the N-methyl-D-aspartate (NMDA) receptor. | Ro 25-6981 |
| sdz eaa 494 | A member of the class of piperazines that is piperazine substituted by a carboxy group at position 2R and a (1E)-1-phosphonoprop-1-en-3-yl group at position 4. It is an antagonist of N-methyl-D-aspartate receptors (NMDARs) and was in clinical development by Novartis for the treatment of cognition disorders and brain injuries (now discontinued). | midafotel |
| sodium selenate | An inorganic sodium salt having selenate as the counterion. | sodium selenate |
| solasodine | An oxaspiro compound and steroid alkaloid sapogenin with formula C27H43NO2 found in the Solanum (nightshade) family. It is used as a precursor in the synthesis of complex steroidal compounds such as contraceptive pills. | solasodine |
| thiopental | A barbiturate, the structure of which is that of 2-thiobarbituric acid substituted at C-5 by ethyl and sec-pentyl groups. | thiopental |
| tiagabine | A piperidinemonocarboxylic acid that is (R)-nipecotic acid in which the hydrogen attached to the nitrogen has been replaced by a 1,1-bis(3-methyl-2-thienyl)but-1-en-4-yl group. A GABA reuptake inhibitor, it is used (generally as the hydrochloride salt) for the treatment of epilepsy. | tiagabine |
| tiagabine hydrochloride | A hydrochloride resulting from the reaction of equimolar amounts of tiagabine and hydrogen chloride. A GABA reuptake inhibitor, it is used for the treatment of epilepsy. | tiagabine hydrochloride |
| topiramate | A hexose derivative that is 2,3:4,5-di-O-isopropylidene-beta-D-fructopyranose in which the hydroxy group has been converted to the corresponding sulfamate ester. It blocks voltage-dependent sodium channels and is used as an antiepileptic and for the prevention of migraine. | topiramate |
| tramiprosate | An amino sulfonic acid that is the 3-amino derivative of propanesulfonic acid. | 3-aminopropanesulfonic acid zwitterion; 3-aminopropanesulfonic acid |
| tricaprylin | A triglyceride obtained by acylation of the three hydroxy groups of glycerol by octanoic acid. Used as an alternative energy source to glucose for patients with mild to moderate Alzheimer's disease. | trioctanoin |
| trimethadione | An oxazolidinone that is 1,3-oxazolidine-2,4-dione substituted by methyl groups at positions 3, 5 and 5. It is an antiepileptic agent. | trimethadione |
| troglitazone | | troglitazone |
| ucb 34714 | A non-proteinogenic amino acid derivative that is butanamide in which the pro-S hydrogen at position 2 is replaced by a (4R)-2-oxo-4-propylpyrrolidin-1-yl. Used for treatment of partial onset seizures related to epilepsy. | brivaracetam |
| valproic acid | A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem. | valproic acid |
| vanillin | A member of the class of benzaldehydes carrying methoxy and hydroxy substituents at positions 3 and 4 respectively. | vanillin |
| vigabatrin | A gamma-amino acid having a gamma-vinyl GABA structure. It is an irreversible inhibitor of gamma-aminobutyric 664 acid transaminase | vigabatrin |
| zaleplon | A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position. | zaleplon |
| zofenopril | A proline derivative that is 4-(phenylsulfanyl)-L-proline in which the amine proton is replaced by a (2S)-3-(benzoylsulfanyl)-2-methylpropanoyl group. A prodrug for zofenoprilat. | zofenopril |
| zofenoprilate | A proline derivative that is 4-(phenylsulfanyl)-L-proline in which the amine proton is replaced by a (2S)-2-methyl-3-sulfanylpropanoyl group. The active metabolite of zofenopril. | zofenoprilat |
| zonisamide | A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position. | zonisamide |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 24.6175 | 1 | 5 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 39.8107 | 1 | 1 |
| 67.9K protein | Vaccinia virus | Potency | 11.2202 | 1 | 1 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 33.3484 | 3 | 7 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 27.5574 | 1 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 22.5734 | 1 | 9 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 14.1254 | 1 | 1 |
| AR protein | Homo sapiens (human) | Potency | 20.0473 | 12 | 59 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 44.2048 | 2 | 7 |
| arylsulfatase A | Homo sapiens (human) | Potency | 4.8443 | 1 | 9 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 12.7932 | 3 | 7 |
| Ataxin-2 | Homo sapiens (human) | Potency | 28.9888 | 1 | 6 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 4.5898 | 1 | 4 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 28.6269 | 2 | 11 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 4.6706 | 1 | 2 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 224.8422 | 2 | 17 |
| BRCA1 | Homo sapiens (human) | Potency | 17.7828 | 1 | 1 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 69.0088 | 1 | 2 |
| caspase-3 | Homo sapiens (human) | Potency | 69.0088 | 1 | 2 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 34.4068 | 3 | 16 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 28.3708 | 2 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 26.1268 | 1 | 4 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | Homo sapiens (human) | Potency | 52.7397 | 2 | 4 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 14.5310 | 2 | 4 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 26.2739 | 3 | 7 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 19.9078 | 2 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 53.1764 | 1 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 14.3471 | 2 | 9 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 17.8192 | 1 | 3 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 36.5080 | 1 | 10 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 19.9078 | 2 | 2 |
| chaperonin-containing TCP-1 beta subunit homolog | Homo sapiens (human) | Potency | 19.9526 | 1 | 1 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 52.1885 | 2 | 10 |
| ClpP | Bacillus subtilis | Potency | 28.1838 | 1 | 1 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 16.3114 | 1 | 2 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 20.5348 | 1 | 4 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 19.7912 | 1 | 10 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 29.9342 | 1 | 7 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 12.2632 | 1 | 5 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 19.8371 | 2 | 20 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 13.0286 | 2 | 14 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 28.2939 | 1 | 17 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 4.5576 | 2 | 7 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 10.2663 | 1 | 2 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| DNA polymerase beta | Homo sapiens (human) | Potency | 89.1251 | 1 | 2 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 39.0992 | 1 | 5 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 31.9161 | 1 | 3 |
| dopamine D1 receptor | Homo sapiens (human) | Potency | 3.4750 | 1 | 3 |
| endonuclease IV | Escherichia coli | Potency | 3.0195 | 1 | 3 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 23.4060 | 10 | 70 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 21.8361 | 2 | 9 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 38.0861 | 7 | 47 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 10.4623 | 1 | 29 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 21.2737 | 4 | 28 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 31.7403 | 3 | 8 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 12.7478 | 1 | 4 |
| G | Vesicular stomatitis virus | Potency | 19.7912 | 1 | 10 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| GALC protein | Homo sapiens (human) | Potency | 0.6823 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 19.8371 | 1 | 10 |
| geminin | Homo sapiens (human) | Potency | 9.5563 | 2 | 29 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 22.9704 | 3 | 30 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 14.5307 | 2 | 3 |
| GLS protein | Homo sapiens (human) | Potency | 15.9347 | 2 | 6 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 53.0097 | 5 | 23 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 26.7461 | 1 | 6 |
| GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 49.1617 | 2 | 3 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 18.6322 | 2 | 16 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 31.0178 | 1 | 9 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 60.1373 | 1 | 1 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 101.2826 | 1 | 3 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 43.0492 | 1 | 3 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 19.7912 | 1 | 10 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 0.9521 | 1 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 10.7409 | 2 | 6 |
| IDH1 | Homo sapiens (human) | Potency | 14.3349 | 1 | 6 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 37.8425 | 2 | 2 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 19.7912 | 1 | 20 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 8.3373 | 1 | 3 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| Interferon beta | Homo sapiens (human) | Potency | 18.0223 | 2 | 11 |
| interleukin 8 | Homo sapiens (human) | Potency | 74.9780 | 1 | 1 |
| isocitrate dehydrogenase 1, partial | Homo sapiens (human) | Potency | 50.1187 | 1 | 1 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 4.2854 | 1 | 14 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 22.1060 | 1 | 2 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 16.2145 | 3 | 5 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 0.1778 | 1 | 1 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 25.9457 | 2 | 12 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 21.1992 | 2 | 6 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 6.2798 | 2 | 10 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 321.7732 | 1 | 2 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 11.9711 | 1 | 3 |
| NFKB1 protein, partial | Homo sapiens (human) | Potency | 6.7740 | 2 | 4 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 10.6101 | 1 | 2 |
| NPC intracellular cholesterol transporter 1 precursor | Homo sapiens (human) | Potency | 5.0451 | 1 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 149.4238 | 3 | 12 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 27.0351 | 1 | 6 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 33.7494 | 1 | 6 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 61.3218 | 1 | 3 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 14.5410 | 2 | 9 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 26.9680 | 1 | 2 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 37.9560 | 3 | 15 |
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | Potency | 0.0100 | 1 | 1 |
| P53 | Homo sapiens (human) | Potency | 26.9680 | 1 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 6.5134 | 1 | 3 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 43.5395 | 2 | 3 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 17.5287 | 2 | 7 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 84.9214 | 1 | 4 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 84.1598 | 4 | 11 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 14.0011 | 3 | 4 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 40.7457 | 2 | 3 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 16.9244 | 1 | 3 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Potency | 8.9125 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 12.9244 | 1 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 14.7036 | 1 | 7 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 32.5549 | 3 | 24 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 278.7106 | 1 | 2 |
| progesterone receptor | Homo sapiens (human) | Potency | 27.1085 | 2 | 7 |
| pyruvate kinase PKM isoform b | Homo sapiens (human) | Potency | 0.0100 | 2 | 2 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 78.1171 | 1 | 2 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 50.1187 | 1 | 1 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 13.8617 | 2 | 13 |
| ras-related protein Rab-9A | Homo sapiens (human) | Potency | 6.8167 | 1 | 3 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 7.3019 | 1 | 7 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 38.3354 | 3 | 19 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 28.1022 | 3 | 15 |
| serine-protein kinase ATM isoform a | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 26.1216 | 1 | 1 |
| serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Potency | 26.6795 | 1 | 1 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 5.6404 | 2 | 2 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 5.6404 | 2 | 2 |
| Smad3 | Homo sapiens (human) | Potency | 22.7406 | 1 | 2 |
| snurportin-1 | Homo sapiens (human) | Potency | 37.8425 | 2 | 2 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 26.6016 | 1 | 5 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 8.2518 | 1 | 5 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 9.5695 | 1 | 5 |
| TDP1 protein | Homo sapiens (human) | Potency | 24.4649 | 2 | 41 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 89.1251 | 1 | 1 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 11.7211 | 4 | 19 |
| Thrombopoietin | Homo sapiens (human) | Potency | 5.0119 | 2 | 2 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 31.1298 | 3 | 27 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 3.7160 | 3 | 6 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 25.8767 | 5 | 15 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 14.7263 | 1 | 1 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 5.4456 | 1 | 2 |
| tumor susceptibility gene 101 protein | Homo sapiens (human) | Potency | 25.1189 | 1 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 11.7406 | 2 | 3 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 16.9244 | 1 | 3 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 16.9244 | 1 | 3 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 38.2265 | 2 | 10 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 47.5904 | 2 | 7 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 6.2925 | 2 | 5 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 44.8455 | 1 | 3 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 26.7461 | 1 | 6 |
| Vpr | Human immunodeficiency virus 1 | Potency | 0.8913 | 1 | 1 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | IC50 | 2.9482 | 2 | 2 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Schizosaccharomyces pombe 972h- | IC50 | 2,488.0000 | 1 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | Homo sapiens (human) | IC50 | 17.1000 | 1 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | Homo sapiens (human) | Ki | 2,025.0000 | 2 | 2 |
| 4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | Ki | 10,000.0000 | 1 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | Sus scrofa (pig) | Ki | 1,745.0000 | 2 | 2 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 0.0278 | 2 | 3 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 78.2515 | 2 | 4 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 0.0103 | 3 | 3 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 3.4055 | 1 | 2 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 4.7780 | 2 | 3 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 0.0103 | 3 | 3 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | IC50 | 11.5530 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 6.0510 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 0.0574 | 5 | 5 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | IC50 | 11.5530 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | Ki | 6.0510 | 1 | 1 |
| Acetylcholinesterase | Homo sapiens (human) | IC50 | 0.1000 | 1 | 2 |
| Acetylcholinesterase | Bos taurus (cattle) | IC50 | 0.1000 | 2 | 3 |
| Acidic mammalian chitinase | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Ki | 0.0336 | 3 | 3 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | Ki | 0.0185 | 3 | 3 |
| Adenosine receptor A3 | Homo sapiens (human) | IC50 | 5.2080 | 1 | 1 |
| Adenosine receptor A3 | Homo sapiens (human) | Ki | 2.9430 | 1 | 1 |
| Aldo-keto reductase family 1 member A1 | Bos taurus (cattle) | IC50 | 57.4000 | 1 | 1 |
| Aldo-keto reductase family 1 member A1 | Homo sapiens (human) | IC50 | 50.1000 | 1 | 1 |
| Aldo-keto reductase family 1 member A1 | Rattus norvegicus (Norway rat) | IC50 | 53.1000 | 2 | 2 |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | IC50 | 100.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 48.3155 | 6 | 6 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 9.3160 | 1 | 1 |
| Aldo-keto reductase family 1 member B7 | Rattus norvegicus (Norway rat) | IC50 | 56.1000 | 1 | 1 |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | IC50 | 2.3533 | 3 | 3 |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | IC50 | 8.7400 | 2 | 2 |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | IC50 | 0.5307 | 3 | 3 |
| Aldo-keto reductase family 1 member C4 | Homo sapiens (human) | IC50 | 100.0000 | 2 | 2 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 2.6043 | 2 | 2 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | Ki | 0.1800 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 2.9430 | 1 | 1 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 5.2080 | 1 | 1 |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | Ki | 0.1800 | 1 | 1 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 2.9430 | 1 | 1 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Ki | 0.1800 | 1 | 1 |
| Amine oxidase [flavin-containing] | Danio rerio (zebrafish) | Ki | 30.8000 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | IC50 | 0.1670 | 3 | 3 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | Ki | 5.2796 | 2 | 2 |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | Ki | 4.8000 | 1 | 1 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | IC50 | 1.3963 | 3 | 3 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | Ki | 4.2163 | 3 | 3 |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | Ki | 6.9000 | 2 | 2 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 233.6590 | 1 | 2 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 0.0120 | 1 | 1 |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | IC50 | 0.0080 | 1 | 1 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | Ki | 0.0004 | 1 | 1 |
| Angiotensin-converting enzyme | Homo sapiens (human) | IC50 | 0.0004 | 1 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | Homo sapiens (human) | Ki | 0.0401 | 1 | 3 |
| Aromatase | Homo sapiens (human) | IC50 | 68,740,988.8231 | 39 | 41 |
| Aromatase | Rattus norvegicus (Norway rat) | IC50 | 20.1000 | 2 | 2 |
| Aromatase | Homo sapiens (human) | Ki | 1.3615 | 13 | 13 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 127.0000 | 1 | 17 |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | IC50 | 1.2850 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 50.0000 | 3 | 3 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | IC50 | 41.5000 | 4 | 4 |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | IC50 | 1.2850 | 1 | 1 |
| bcl-2-related protein A1 | Mus musculus (house mouse) | IC50 | 100.0000 | 2 | 2 |
| Beta-carbonic anhydrase 1 | Mycobacterium tuberculosis H37Rv | Ki | 23.3392 | 9 | 15 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 347.3257 | 7 | 46 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 602.9000 | 2 | 5 |
| BZLF2 | Human herpesvirus 4 type 2 (Epstein-Barr virus type 2) | IC50 | 2.0300 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 133.0000 | 1 | 15 |
| Cannabinoid receptor 1 | Homo sapiens (human) | Ki | 5.0000 | 2 | 3 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | Ki | 0.0390 | 2 | 2 |
| Cannabinoid receptor 2 | Homo sapiens (human) | Ki | 5.0000 | 2 | 3 |
| Carbonic anhydrase | Candida albicans SC5314 | Ki | 0.5580 | 8 | 19 |
| Carbonic anhydrase | Dicentrarchus labrax (European seabass) | Ki | 5.7200 | 1 | 1 |
| Carbonic anhydrase | Flaveria bidentis | Ki | 0.0270 | 4 | 4 |
| Carbonic anhydrase | Helicobacter pylori 26695 | Ki | 0.1445 | 2 | 6 |
| Carbonic anhydrase | Methanosarcina thermophila | Ki | 0.3418 | 8 | 10 |
| Carbonic anhydrase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 14.3800 | 4 | 5 |
| Carbonic anhydrase | Saccharomyces cerevisiae S288C | Ki | 2.3635 | 5 | 7 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.3620 | 1 | 3 |
| Carbonic anhydrase | Anopheles gambiae (African malaria mosquito) | Ki | 33.4301 | 1 | 3 |
| Carbonic anhydrase | Astrosclera willeyana | Ki | 176.0610 | 2 | 5 |
| Carbonic anhydrase | Cryptococcus neoformans var. grubii | Ki | 0.2132 | 9 | 13 |
| Carbonic anhydrase | Drosophila melanogaster (fruit fly) | Ki | 0.1060 | 1 | 1 |
| Carbonic anhydrase | Mycobacterium tuberculosis H37Rv | Ki | 0.4698 | 6 | 8 |
| Carbonic anhydrase | Nakaseomyces glabratus CBS 138 | Ki | 0.0399 | 5 | 7 |
| Carbonic anhydrase | Pseudomonas aeruginosa PAO1 | Ki | 11,750.0380 | 1 | 2 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.1014 | 2 | 6 |
| Carbonic anhydrase | Sulfurihydrogenibium sp. YO3AOP1 | Ki | 0.0504 | 1 | 3 |
| Carbonic anhydrase 1 | Homo sapiens (human) | IC50 | 2.8580 | 44 | 58 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 1,054.1339 | 489 | 790 |
| Carbonic anhydrase 12 | Homo sapiens (human) | IC50 | 0.5106 | 8 | 8 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 10.5393 | 245 | 353 |
| Carbonic anhydrase 13 | Homo sapiens (human) | IC50 | 0.7733 | 3 | 3 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | IC50 | 0.7700 | 2 | 2 |
| Carbonic anhydrase 13 | Homo sapiens (human) | Ki | 31.3457 | 22 | 72 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | Ki | 6,223.0231 | 19 | 78 |
| Carbonic anhydrase 14 | Homo sapiens (human) | IC50 | 0.5184 | 5 | 5 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Ki | 25.4088 | 52 | 145 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | Ki | 0.1664 | 9 | 18 |
| Carbonic anhydrase 2 | Bos taurus (cattle) | IC50 | 0.9900 | 4 | 4 |
| Carbonic anhydrase 2 | Homo sapiens (human) | IC50 | 1.6407 | 96 | 113 |
| Carbonic anhydrase 2 | Rattus norvegicus (Norway rat) | IC50 | 1.4000 | 1 | 1 |
| Carbonic anhydrase 2 | Bos taurus (cattle) | Ki | 0.1370 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 2,270.4436 | 516 | 841 |
| Carbonic anhydrase 2 | Mycobacterium tuberculosis H37Rv | Ki | 0.4530 | 1 | 3 |
| Carbonic anhydrase 2, isoform A | Drosophila melanogaster (fruit fly) | Ki | 0.0780 | 1 | 1 |
| Carbonic anhydrase 3 | Homo sapiens (human) | IC50 | 1.9320 | 5 | 5 |
| Carbonic anhydrase 3 | Bos taurus (cattle) | Ki | 65.9145 | 4 | 20 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Ki | 147.1345 | 39 | 114 |
| Carbonic anhydrase 4 | Bos taurus (cattle) | IC50 | 0.0647 | 2 | 3 |
| Carbonic anhydrase 4 | Homo sapiens (human) | IC50 | 0.4693 | 4 | 5 |
| Carbonic anhydrase 4 | Bos taurus (cattle) | Ki | 0.1448 | 21 | 43 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 676.9855 | 95 | 211 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | IC50 | 0.5973 | 4 | 4 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Ki | 24.1312 | 57 | 157 |
| Carbonic anhydrase 5A, mitochondrial | Mus musculus (house mouse) | Ki | 0.1997 | 2 | 14 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | IC50 | 0.7733 | 3 | 3 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Ki | 67.4632 | 46 | 145 |
| Carbonic anhydrase 6 | Homo sapiens (human) | IC50 | 6.5383 | 4 | 6 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Ki | 32.2531 | 45 | 145 |
| Carbonic anhydrase 7 | Homo sapiens (human) | IC50 | 1.2717 | 7 | 7 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 1,002.9894 | 90 | 218 |
| Carbonic anhydrase 7 | Mus musculus (house mouse) | Ki | 0.0160 | 1 | 1 |
| Carbonic anhydrase 9 | Homo sapiens (human) | IC50 | 0.4834 | 72 | 72 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 8.0114 | 333 | 471 |
| Carbonic anhydrase-related protein 11 | Homo sapiens (human) | Ki | 0.0057 | 1 | 1 |
| Carbonic anhydrase, alpha family | Hydrogenovibrio crunogenus XCL-2 | Ki | 0.3948 | 1 | 3 |
| Carboxylic ester hydrolase | Equus caballus (horse) | IC50 | 0.1000 | 1 | 1 |
| Cathepsin B | Bos taurus (cattle) | IC50 | 0.0200 | 1 | 1 |
| Cationic amino acid transporter 3 | Homo sapiens (human) | IC50 | 158.0000 | 1 | 1 |
| Chain A, Carbonic anhydrase | Coccomyxa sp. PA | Ki | 1.0000 | 1 | 1 |
| Chain A, Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 0.2500 | 1 | 1 |
| Chain A, Carbonic anhydrase 13 | Homo sapiens (human) | Ki | 0.0160 | 1 | 1 |
| Chain A, Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 0.0061 | 1 | 10 |
| Chain A, Carbonic anhydrase II | Homo sapiens (human) | Ki | 0.0049 | 1 | 1 |
| Chain A, Class Iii Chitinase Chia1 | Aspergillus fumigatus A1163 | IC50 | 164.0000 | 1 | 1 |
| Chain A, Cytosol aminopeptidase | Bos taurus (cattle) | Ki | 0.8000 | 1 | 1 |
| Chain A, Endochitinase | Saccharomyces cerevisiae (brewer's yeast) | Ki | 21.0000 | 1 | 3 |
| Chain A, retinol dehydratase | Spodoptera frugiperda (fall armyworm) | Ki | 0.1100 | 1 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | Pisum sativum (garden pea) | Ki | 36,600.0000 | 1 | 2 |
| Chain B, Carbonic anhydrase | Coccomyxa sp. PA | Ki | 1.0000 | 1 | 1 |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | IC50 | 64.0000 | 1 | 1 |
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | IC50 | 92.8000 | 3 | 5 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | Homo sapiens (human) | IC50 | 80.0000 | 1 | 1 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | Bos taurus (cattle) | IC50 | 29.6667 | 3 | 3 |
| Cholinesterase | Homo sapiens (human) | IC50 | 5.4000 | 2 | 3 |
| Cholinesterase | Equus caballus (horse) | Ki | 0.2500 | 1 | 1 |
| Cocaine esterase | Homo sapiens (human) | Ki | 7,900.0000 | 1 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Mus musculus (house mouse) | Ki | 0.0100 | 1 | 1 |
| Corticosteroid-binding globulin | Homo sapiens (human) | Ki | 2.4547 | 1 | 1 |
| Corticotropin-releasing factor receptor 2 | Homo sapiens (human) | Ki | 5.0000 | 1 | 1 |
| Cystathionine beta-synthase | Homo sapiens (human) | IC50 | 5.2750 | 4 | 4 |
| Cystathionine gamma-lyase | Homo sapiens (human) | IC50 | 2.2850 | 2 | 2 |
| Cytochrome P450 11B2, mitochondrial | Rattus norvegicus (Norway rat) | IC50 | 70.0000 | 2 | 3 |
| Cytochrome P450 1A1 | Homo sapiens (human) | IC50 | 0.0830 | 2 | 2 |
| Cytochrome P450 1A1 | Homo sapiens (human) | Ki | 29.5225 | 2 | 2 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 36.7770 | 3 | 3 |
| Cytochrome P450 1A2 | Homo sapiens (human) | Ki | 1.0270 | 4 | 12 |
| Cytochrome P450 1A2 | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Cytochrome P450 1B1 | Homo sapiens (human) | IC50 | 0.0110 | 3 | 3 |
| Cytochrome P450 1B1 | Homo sapiens (human) | Ki | 4.6713 | 3 | 3 |
| Cytochrome P450 2A6 | Homo sapiens (human) | Ki | 1,830.0124 | 3 | 5 |
| Cytochrome P450 2B6 | Homo sapiens (human) | Ki | 0.0398 | 2 | 4 |
| Cytochrome P450 2C11 | Rattus norvegicus (Norway rat) | Ki | 0.0003 | 1 | 1 |
| Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 1.1850 | 2 | 2 |
| Cytochrome P450 2C19 | Homo sapiens (human) | Ki | 0.0676 | 5 | 7 |
| Cytochrome P450 2C8 | Homo sapiens (human) | Ki | 0.0326 | 4 | 9 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 34.6667 | 2 | 3 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 1.6152 | 6 | 10 |
| Cytochrome P450 2D6 | Homo sapiens (human) | Ki | 0.0487 | 6 | 10 |
| Cytochrome P450 2J2 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 2 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 2.7427 | 3 | 3 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 0.0379 | 8 | 15 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Ki | 0.0120 | 1 | 1 |
| D(2) dopamine receptor | Homo sapiens (human) | Ki | 0.0103 | 6 | 9 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 1.5294 | 2 | 4 |
| D(3) dopamine receptor | Homo sapiens (human) | Ki | 0.0006 | 3 | 4 |
| Delta carbonic anhydrase | Conticribra weissflogii | Ki | 0.2930 | 1 | 3 |
| Delta-type opioid receptor | Mus musculus (house mouse) | IC50 | 0.1380 | 2 | 2 |
| Delta-type opioid receptor | Mus musculus (house mouse) | Ki | 0.1022 | 2 | 6 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0175 | 2 | 6 |
| Dihydrofolate reductase | Escherichia coli K-12 | IC50 | 348.9000 | 1 | 1 |
| Dihydrofolate reductase | Escherichia coli K-12 | Ki | 15.2400 | 1 | 1 |
| Dihydrofolate reductase | Bos taurus (cattle) | IC50 | 100.0000 | 1 | 1 |
| Dipeptidyl peptidase 4 | Sus scrofa (pig) | IC50 | 0.4900 | 1 | 1 |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | IC50 | 1,500.0000 | 1 | 1 |
| E3 ubiquitin-protein ligase TRIM33 | Homo sapiens (human) | IC50 | 0.3256 | 1 | 1 |
| Endochitinase | Saccharomyces cerevisiae S288C | Ki | 21.0000 | 1 | 1 |
| Endochitinase A1 | Aspergillus fumigatus | IC50 | 164.0000 | 1 | 1 |
| Fatty acid-binding protein, intestinal | Homo sapiens (human) | Ki | 8.9000 | 1 | 1 |
| Fatty acid-binding protein, liver | Rattus norvegicus (Norway rat) | Ki | 29.0415 | 2 | 4 |
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | IC50 | 21.4000 | 3 | 4 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | IC50 | 290.9260 | 5 | 7 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | Ki | 0.0250 | 1 | 1 |
| Forkhead box protein M1 | Homo sapiens (human) | IC50 | 122.4000 | 1 | 1 |
| Forkhead box protein M1 | Homo sapiens (human) | Ki | 0.0520 | 1 | 1 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Ki | 10.5326 | 16 | 19 |
| Gamma-aminobutyric acid | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | IC50 | 98,444.1133 | 6 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 279.7299 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Bos taurus (cattle) | Ki | 0.0074 | 7 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Ki | 5.6213 | 16 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 7.7856 | 24 | 27 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Bos taurus (cattle) | Ki | 0.0074 | 7 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | Ki | 6.3248 | 14 | 16 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 10.4801 | 20 | 23 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Bos taurus (cattle) | Ki | 0.0074 | 7 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | Ki | 5.9556 | 15 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 8.3414 | 21 | 24 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Bos taurus (cattle) | Ki | 0.0074 | 7 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | Ki | 20.2042 | 4 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 10.5326 | 16 | 19 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | IC50 | 126,559.0053 | 4 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Ki | 7.7772 | 11 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Ki | 9.0978 | 19 | 22 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | Ki | 14.7526 | 7 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Ki | 8.6899 | 22 | 25 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Bos taurus (cattle) | Ki | 0.0074 | 7 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | Ki | 16.8388 | 5 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Ki | 10.5326 | 16 | 19 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | Ki | 6.0597 | 14 | 19 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 6.1461 | 34 | 37 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | IC50 | 88,599.7037 | 7 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | Ki | 3.1660 | 32 | 33 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Ki | 9.5305 | 18 | 21 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | Ki | 20.2042 | 4 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Ki | 10.5326 | 16 | 19 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | Ki | 20.2042 | 4 | 5 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Ki | 10.5326 | 16 | 19 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | IC50 | 273.2246 | 28 | 43 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | Ki | 20.2042 | 4 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Ki | 10.5326 | 16 | 19 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Bos taurus (cattle) | IC50 | 0.0299 | 3 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | IC50 | 88,599.7037 | 7 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Bos taurus (cattle) | Ki | 0.0074 | 7 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | Ki | 2.4709 | 43 | 48 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Ki | 5.8314 | 36 | 39 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | IC50 | 279.7298 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | Ki | 20.2042 | 4 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Ki | 10.5326 | 16 | 19 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit pi | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | IC50 | 279.7299 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | Ki | 20.2042 | 4 | 5 |
| Gamma-aminobutyric acid receptor subunit pi | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Ki | 10.5326 | 16 | 19 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | IC50 | 147,652.1700 | 3 | 6 |
| Gamma-aminobutyric acid receptor subunit theta | Mus musculus (house mouse) | IC50 | 0.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | Ki | 20.2042 | 4 | 5 |
| Gamma-aminobutyric acid receptor subunit theta | Mus musculus (house mouse) | Ki | 104.3333 | 1 | 9 |
| Gamma-aminobutyric acid type B receptor subunit 1 | Homo sapiens (human) | Ki | 3,200.0000 | 1 | 2 |
| Gamma-aminobutyric acid type B receptor subunit 2 | Homo sapiens (human) | Ki | 3,200.0000 | 1 | 2 |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Glutamate receptor 1 | Homo sapiens (human) | IC50 | 1.8082 | 5 | 5 |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | IC50 | 0.0270 | 5 | 5 |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | Ki | 0.0059 | 4 | 5 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | IC50 | 3.4898 | 14 | 15 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Ki | 0.0318 | 6 | 10 |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | IC50 | 13.0102 | 4 | 4 |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | Ki | 0.0049 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | IC50 | 4.7548 | 11 | 11 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Ki | 0.0318 | 6 | 10 |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | IC50 | 0.0219 | 7 | 7 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | IC50 | 0.0320 | 15 | 16 |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | Ki | 0.0338 | 5 | 6 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Ki | 0.0335 | 7 | 12 |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | IC50 | 0.0060 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | IC50 | 0.0303 | 10 | 10 |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | Ki | 0.0049 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Ki | 0.0318 | 6 | 10 |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | IC50 | 0.0060 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | IC50 | 0.0303 | 10 | 10 |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | Ki | 0.0049 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Ki | 0.0318 | 6 | 10 |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | IC50 | 0.0060 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | IC50 | 0.0303 | 10 | 10 |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | Ki | 0.0049 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Ki | 0.0318 | 6 | 10 |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | IC50 | 0.0060 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | IC50 | 0.0303 | 10 | 10 |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | Ki | 0.0049 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Ki | 0.0318 | 6 | 10 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | IC50 | 61.2000 | 1 | 1 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | Ki | 54.6000 | 1 | 1 |
| Glycogen phosphorylase, muscle form | Oryctolagus cuniculus (rabbit) | Ki | 0.0410 | 1 | 1 |
| Histamine H3 receptor | Homo sapiens (human) | Ki | 0.0005 | 1 | 1 |
| Histone deacetylase 1 | Homo sapiens (human) | IC50 | 1,262.6014 | 7 | 7 |
| Histone deacetylase 1 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Histone deacetylase 11 | Homo sapiens (human) | IC50 | 4,117.5000 | 2 | 2 |
| Histone deacetylase 11 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Histone deacetylase 2 | Homo sapiens (human) | IC50 | 1,819.9480 | 5 | 5 |
| Histone deacetylase 2 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Histone deacetylase 3 | Homo sapiens (human) | IC50 | 1,846.1340 | 5 | 5 |
| Histone deacetylase 3 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Histone deacetylase 4 | Homo sapiens (human) | IC50 | 2,808.7500 | 4 | 4 |
| Histone deacetylase 4 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Histone deacetylase 5 | Homo sapiens (human) | IC50 | 2,808.7500 | 4 | 4 |
| Histone deacetylase 5 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Histone deacetylase 6 | Homo sapiens (human) | IC50 | 2,290.0020 | 5 | 5 |
| Histone deacetylase 6 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Histone deacetylase 7 | Homo sapiens (human) | IC50 | 3,411.6667 | 3 | 3 |
| Histone deacetylase 7 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Histone deacetylase 8 | Homo sapiens (human) | IC50 | 2,130.5750 | 4 | 4 |
| Histone deacetylase 8 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Histone deacetylase 9 | Homo sapiens (human) | IC50 | 3,411.6667 | 3 | 3 |
| Histone deacetylase 9 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Histone-lysine N-methyltransferase EHMT1 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Histone-lysine N-methyltransferase EHMT2 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | Mus musculus (house mouse) | IC50 | 61.0000 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | IC50 | 4.5000 | 1 | 1 |
| Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | IC50 | 5.7000 | 1 | 1 |
| Inositol polyphosphate multikinase | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.2500 | 1 | 1 |
| Liver carboxylesterase 1 | Homo sapiens (human) | Ki | 363.0000 | 1 | 1 |
| Lysine-specific demethylase 4C | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Lysine-specific demethylase 4C | Homo sapiens (human) | Ki | 200.0000 | 1 | 1 |
| Lysosomal Pro-X carboxypeptidase | Homo sapiens (human) | IC50 | 0.0053 | 1 | 1 |
| MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | IC50 | 1.2050 | 1 | 1 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | IC50 | 0.2520 | 1 | 1 |
| Melatonin receptor type 1A | Homo sapiens (human) | IC50 | 0.0025 | 18 | 18 |
| Melatonin receptor type 1A | Gallus gallus (chicken) | Ki | 0.0007 | 7 | 8 |
| Melatonin receptor type 1A | Homo sapiens (human) | Ki | 0.0003 | 67 | 69 |
| Melatonin receptor type 1B | Homo sapiens (human) | IC50 | 0.0035 | 12 | 12 |
| Melatonin receptor type 1B | Gallus gallus (chicken) | Ki | 0.0007 | 8 | 9 |
| Melatonin receptor type 1B | Homo sapiens (human) | Ki | 0.0004 | 62 | 64 |
| Melatonin receptor type 1C | Gallus gallus (chicken) | Ki | 0.0007 | 7 | 8 |
| Metabotropic glutamate receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 0.0004 | 2 | 2 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | IC50 | 2.1910 | 1 | 2 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | IC50 | 27.2950 | 1 | 4 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 27.2950 | 1 | 4 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.1114 | 3 | 5 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 12,455.6228 | 6 | 9 |
| Multidrug resistance-associated protein 1 | Rattus norvegicus (Norway rat) | Ki | 0.0161 | 3 | 4 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 128.7647 | 1 | 17 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | IC50 | 0.0020 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Myeloperoxidase | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | IC50 | 35.1667 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 0.0054 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 | Rattus norvegicus (Norway rat) | Ki | 3.8337 | 2 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 0.0054 | 1 | 2 |
| Nociceptin receptor | Mus musculus (house mouse) | Ki | 0.0003 | 1 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | IC50 | 35.8500 | 2 | 2 |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | IC50 | 35.8500 | 2 | 2 |
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | IC50 | 0.8337 | 1 | 1 |
| P2X purinoceptor 4 | Homo sapiens (human) | IC50 | 57.5000 | 1 | 4 |
| Palmitoleoyl-protein carboxylesterase NOTUM | Homo sapiens (human) | IC50 | 75.4000 | 1 | 1 |
| Pancreatic triacylglycerol lipase | Sus scrofa (pig) | IC50 | 74.4000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | IC50 | 1.0300 | 6 | 6 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | Ki | 0.3168 | 5 | 5 |
| polyadenylate-binding protein 1 | Homo sapiens (human) | IC50 | 47.0500 | 2 | 2 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | IC50 | 4,117.5000 | 2 | 2 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | Ki | 564.0000 | 1 | 1 |
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 | 4,103.0000 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | IC50 | 57.0667 | 3 | 3 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | Ki | 0.0401 | 1 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 7.5960 | 1 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | IC50 | 3.3000 | 2 | 2 |
| Potassium voltage-gated channel subfamily D member 3 | Homo sapiens (human) | IC50 | 9.3000 | 1 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | Homo sapiens (human) | IC50 | 119.9445 | 2 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 907.2057 | 8 | 12 |
| Potassium voltage-gated channel subfamily KQT member 1 | Homo sapiens (human) | IC50 | 119.9445 | 2 | 2 |
| Prolyl endopeptidase | Sus scrofa (pig) | IC50 | 0.0060 | 1 | 1 |
| Prolyl endopeptidase | Rattus norvegicus (Norway rat) | Ki | 0.0487 | 1 | 3 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 1.4183 | 2 | 3 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | IC50 | 0.0675 | 2 | 4 |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | IC50 | 0.1000 | 2 | 2 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 0.8530 | 5 | 7 |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | IC50 | 0.1640 | 3 | 5 |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | IC50 | 0.1000 | 2 | 2 |
| Proton-coupled amino acid transporter 1 | Homo sapiens (human) | Ki | 7,250.0000 | 1 | 2 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | IC50 | 0.5250 | 3 | 6 |
| Renin | Homo sapiens (human) | IC50 | 8.2000 | 1 | 1 |
| Renin | Macaca mulatta (Rhesus monkey) | IC50 | 8.2000 | 1 | 1 |
| Renin | Homo sapiens (human) | Ki | 3.3000 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 175.0000 | 1 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | IC50 | 6.5332 | 8 | 9 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | Ki | 0.0422 | 2 | 2 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | IC50 | 5.0000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Secreted chorismate mutase | Mycobacterium tuberculosis H37Rv | IC50 | 24.8000 | 1 | 1 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | IC50 | 2.7100 | 2 | 2 |
| Serum paraoxonase/arylesterase 1 | Homo sapiens (human) | Ki | 743.0000 | 1 | 1 |
| Sialidase-2 | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | Ki | 0.0120 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 5.8500 | 2 | 2 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | Ki | 5.1250 | 2 | 2 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Ki | 59.1670 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | Ki | 59.1670 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | IC50 | 14.2500 | 1 | 2 |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 116.3800 | 2 | 5 |
| Sodium channel protein type 10 subunit alpha | Homo sapiens (human) | IC50 | 97.0000 | 2 | 2 |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | IC50 | 50.7857 | 5 | 7 |
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 80.9000 | 4 | 11 |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | IC50 | 15.1667 | 2 | 3 |
| Sodium channel protein type 3 subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 116.3800 | 2 | 5 |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | Ki | 31.0000 | 1 | 3 |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | IC50 | 70.1621 | 5 | 5 |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | IC50 | 46.3333 | 3 | 3 |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | Ki | 32.7000 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | Homo sapiens (human) | IC50 | 1,670.0000 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | Mus musculus (house mouse) | IC50 | 150.1350 | 4 | 4 |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | IC50 | 18.9000 | 1 | 2 |
| Sodium- and chloride-dependent GABA transporter 1 | Homo sapiens (human) | IC50 | 0.1868 | 5 | 5 |
| Sodium- and chloride-dependent GABA transporter 1 | Mus musculus (house mouse) | IC50 | 0.1907 | 18 | 19 |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 4.1741 | 6 | 17 |
| Sodium- and chloride-dependent GABA transporter 1 | Homo sapiens (human) | Ki | 0.0324 | 2 | 2 |
| Sodium- and chloride-dependent GABA transporter 1 | Mus musculus (house mouse) | Ki | 0.0383 | 9 | 9 |
| Sodium- and chloride-dependent GABA transporter 2 | Mus musculus (house mouse) | IC50 | 300.0000 | 2 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | IC50 | 482.6000 | 2 | 3 |
| Sodium- and chloride-dependent GABA transporter 3 | Homo sapiens (human) | IC50 | 917.0000 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | Mus musculus (house mouse) | IC50 | 800.0000 | 2 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | IC50 | 18.9000 | 1 | 2 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | Ki | 0.0352 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 9.6965 | 2 | 2 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 9.6580 | 2 | 2 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | Ki | 0.1310 | 2 | 2 |
| Solute carrier family 15 member 1 | Rattus norvegicus (Norway rat) | Ki | 8,000.0000 | 1 | 1 |
| Solute carrier family 15 member 2 | Homo sapiens (human) | IC50 | 28.0000 | 1 | 1 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | Ki | 66.0000 | 1 | 1 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | Ki | 3.7000 | 1 | 1 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | Ki | 1,100.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A1 | Rattus norvegicus (Norway rat) | Ki | 10.6000 | 1 | 1 |
| Sphingosine-1-phosphate lyase 1 | Mus musculus (house mouse) | Ki | 0.0150 | 1 | 1 |
| Squalene synthase | Rattus norvegicus (Norway rat) | Ki | 0.0090 | 2 | 2 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | Homo sapiens (human) | IC50 | 60.0000 | 1 | 1 |
| steroidogenic factor 1 | Homo sapiens (human) | IC50 | 67.5360 | 1 | 1 |
| Sterol O-acyltransferase 1 | Rattus norvegicus (Norway rat) | IC50 | 50.0000 | 1 | 1 |
| Steryl-sulfatase | Homo sapiens (human) | IC50 | 5.0125 | 1 | 2 |
| Substance-K receptor | Cavia porcellus (domestic guinea pig) | IC50 | 46.3000 | 1 | 1 |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | IC50 | 46.3000 | 1 | 1 |
| Succinate-semialdehyde dehydrogenase, mitochondrial | Homo sapiens (human) | IC50 | 15.6000 | 1 | 1 |
| Synaptic vesicle glycoprotein 2A | Rattus norvegicus (Norway rat) | IC50 | 5,629,465,000,000.0000 | 1 | 2 |
| Thromboxane-A synthase | Homo sapiens (human) | IC50 | 14.6165 | 3 | 4 |
| Tissue factor | Homo sapiens (human) | IC50 | 1,750.0000 | 2 | 2 |
| TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | IC50 | 33.5500 | 1 | 1 |
| Transcription factor p65 | Homo sapiens (human) | IC50 | 35.8500 | 2 | 2 |
| Transcription factor SOX-18 | Mus musculus (house mouse) | IC50 | 163.0000 | 2 | 2 |
| Transcription intermediary factor 1-alpha | Homo sapiens (human) | IC50 | 0.1620 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | IC50 | 4.6350 | 3 | 4 |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | IC50 | 10.0000 | 2 | 2 |
| Translocator protein | Homo sapiens (human) | IC50 | 221,478.2500 | 1 | 4 |
| Translocator protein | Bos taurus (cattle) | Ki | 0.0009 | 1 | 2 |
| Translocator protein | Rattus norvegicus (Norway rat) | Ki | 9.7587 | 3 | 4 |
| Triosephosphate isomerase | Oryctolagus cuniculus (rabbit) | Ki | 1.4100 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | IC50 | 55.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | IC50 | 75.5000 | 1 | 4 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | Ki | 20.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 75.5000 | 1 | 4 |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | IC50 | 75.5000 | 1 | 4 |
| UDP-glucuronosyltransferase 2B10 | Homo sapiens (human) | IC50 | 75.5000 | 1 | 4 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | IC50 | 75.5000 | 1 | 4 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | Ki | 1,600.0000 | 1 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Homo sapiens (human) | Ki | 0.0190 | 2 | 2 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Mus musculus (house mouse) | Ki | 0.1201 | 1 | 2 |
| Voltage-dependent calcium channel subunit alpha-2/delta-2 | Homo sapiens (human) | Ki | 0.0990 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | IC50 | 125.0000 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 604.2440 | 5 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 26.2000 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 26.2000 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 26.2000 | 2 | 2 |
| Voltage-dependent T-type calcium channel subunit alpha-1I | Homo sapiens (human) | IC50 | 5,000.0000 | 1 | 1 |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | IC50 | 14.1000 | 1 | 1 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Albumin | Homo sapiens (human) | Kd | 24.5471 | 1 | 1 |
| Albumin | Rattus norvegicus (Norway rat) | Kd | 59.0500 | 1 | 2 |
| Aromatase | Rattus norvegicus (Norway rat) | EC50 | 0.2600 | 1 | 1 |
| Bromodomain-containing protein 4 | Homo sapiens (human) | Kd | 2.4600 | 1 | 1 |
| calcineurin A1, putative | Candida dubliniensis CD36 | EC50 | 180.0000 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Kd | 0.9155 | 12 | 16 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Kd | 0.1872 | 11 | 15 |
| Carbonic anhydrase 13 | Homo sapiens (human) | Kd | 0.1214 | 14 | 18 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Kd | 0.0198 | 5 | 5 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Kd | 83.4404 | 19 | 24 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Kd | 61.7250 | 5 | 5 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Kd | 0.0625 | 5 | 5 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Kd | 0.4984 | 6 | 7 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Kd | 0.1742 | 5 | 5 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Kd | 0.1740 | 6 | 6 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Kd | 0.1359 | 9 | 13 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Kd | 0.0145 | 12 | 12 |
| Chain A, CARBONIC ANHYDRASE II | Homo sapiens (human) | Kd | 22,727.3743 | 1 | 11 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Kd | 460.0000 | 1 | 7 |
| Cytochrome P450 2B6 | Homo sapiens (human) | EC50 | 145.0000 | 1 | 1 |
| Frizzled-8 | Mus musculus (house mouse) | Kd | 16.8000 | 1 | 1 |
| G-protein coupled bile acid receptor 1 | Homo sapiens (human) | EC50 | 6.2200 | 1 | 1 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | EC50 | 13.7852 | 13 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Kd | 0.0360 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | EC50 | 11.3462 | 6 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | EC50 | 11.2800 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | EC50 | 27.6000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | EC50 | 11.2510 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Kd | 0.0230 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | EC50 | 27.6000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | EC50 | 26.8000 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | EC50 | 9.8588 | 8 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | EC50 | 10.7765 | 11 | 11 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | EC50 | 8.6257 | 16 | 16 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | EC50 | 1.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | EC50 | 50.0000 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Kd | 0.0372 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Kd | 0.0372 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Kd | 0.0372 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Kd | 0.0372 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Kd | 0.0372 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Kd | 0.0372 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Kd | 0.0372 | 1 | 1 |
| heat shock protein 90 | Candida albicans | EC50 | 120.0330 | 3 | 4 |
| Major prion protein | Homo sapiens (human) | EC50 | 10.0000 | 1 | 1 |
| Melatonin receptor type 1A | Gallus gallus (chicken) | EC50 | 0.0226 | 1 | 1 |
| Melatonin receptor type 1A | Homo sapiens (human) | EC50 | 0.0008 | 11 | 11 |
| Melatonin receptor type 1B | Gallus gallus (chicken) | EC50 | 0.0226 | 1 | 1 |
| Melatonin receptor type 1B | Homo sapiens (human) | EC50 | 0.0025 | 12 | 12 |
| Melatonin receptor type 1C | Gallus gallus (chicken) | EC50 | 0.0226 | 1 | 1 |
| Melatonin receptor type 1C | Xenopus laevis (African clawed frog) | EC50 | 0.0001 | 3 | 3 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | EC50 | 1.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | EC50 | 0.7800 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | EC50 | 0.7800 | 1 | 2 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | EC50 | 0.7800 | 1 | 2 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | EC50 | 0.7800 | 1 | 2 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | EC50 | 0.7800 | 1 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | EC50 | 15.8000 | 3 | 3 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | EC50 | 1.1000 | 19 | 19 |
| Peroxisome proliferator-activated receptor gamma | Mus musculus (house mouse) | EC50 | 3.0267 | 3 | 3 |
| POsterior Segregation | Caenorhabditis elegans | EC50 | 16.7190 | 1 | 1 |
| Potassium voltage-gated channel subfamily KQT member 2 | Homo sapiens (human) | EC50 | 2.6220 | 10 | 10 |
| Potassium voltage-gated channel subfamily KQT member 2 | Rattus norvegicus (Norway rat) | EC50 | 2.7867 | 3 | 3 |
| Potassium voltage-gated channel subfamily KQT member 2 | Mus musculus (house mouse) | EC50 | 1.3000 | 3 | 3 |
| Potassium voltage-gated channel subfamily KQT member 3 | Homo sapiens (human) | EC50 | 4.0217 | 6 | 6 |
| Potassium voltage-gated channel subfamily KQT member 3 | Rattus norvegicus (Norway rat) | EC50 | 4.1500 | 1 | 1 |
| Potassium voltage-gated channel subfamily KQT member 4 | Homo sapiens (human) | EC50 | 3.9400 | 2 | 2 |
| Potassium voltage-gated channel subfamily KQT member 5 | Homo sapiens (human) | EC50 | 2.1250 | 2 | 2 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | Kd | 220.0000 | 1 | 1 |
| Sex hormone-binding globulin | Homo sapiens (human) | Kd | 0.0708 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | EC50 | 0.1500 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | Homo sapiens (human) | Kd | 0.0937 | 2 | 2 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | EC50 | 12.2720 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | EC50 | 25.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | EC50 | 10.0000 | 2 | 2 |
| Translocator protein | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Transthyretin | Homo sapiens (human) | Kd | 0.4800 | 1 | 1 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A10 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A3 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A5 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A7 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A8 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A9 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 2A1 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 2A2 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 2A3 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 2B10 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 2B11 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 2B15 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 2B17 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 2B28 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 2B4 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | EC50 | 3.9000 | 1 | 1 |
| Zinc finger protein mex-5 | Caenorhabditis elegans | EC50 | 12.2720 | 1 | 1 |